Szubert, A. J., Pollock, K. M., Cheeseman, H. M., Alagaratnam, J., Bern, H., Bird, O., Boffito, M., Byrne, R., Cole, T., Cosgrove, C. A., Faust, S. N., Fidler, S., Galiza, E., Hassanin, H., Kalyan, M., Libri, V., McFarlane, L. R., Milinkovic, A., O'Hara, J., Owen, D. R., Owens, D., Pacurar, M., Rampling, T., Skene, S., Winston, A., Woolley, J., Yim, Y. T. N., Dunn, D. T., McCormack, S., Shattock, R. J., & , (2023). cOVAC1 phase 2a expanded safety and immunogenicity study of a self-amplifying RNA vaccine against SARS-CoV-2. EClinicalMedicine, 56, . http://access.bl.uk/ark:/81055/vdc_100179406708.0x000003